# US Extracorporeal Membrane Oxygenation Machine Market

> US Extracorporeal Membrane Oxygenation Machine Market Research Report: Size, Share, Trend Analysis By Applications (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO) and By Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.27%
- **2024:** $ 456.6 Million
- **2025:** $ 485.23 Million
- **2035:** $ 891.2 Million
- **Key Players:** Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US)

**Report ID:** MRFR/HC/13082-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-extracorporeal-membrane-oxygenation-machine-market-14609

---

## Market Summary

## **US Extracorporeal Membrane Oxygenation Machine Market Overview**

**As per MRFR analysis, the US Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 431.2 (USD Million) in 2023. The US Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 455.7(USD Million) in 2024 to 1,058 (USD Million) by 2035. The US Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 7.958% during the forecast period (2025 - 2035).**

### **Key US Extracorporeal Membrane Oxygenation Machine Market Trends Highlighted**

The US Extracorporeal Membrane Oxygenation (ECMO) machine market is witnessing significant trends driven by the increasing prevalence of respiratory and cardiac conditions, which has heightened the demand for advanced life-support systems. A key market driver is the growing awareness among healthcare professionals about the efficacy of ECMO in critical care settings, particularly for patients with severe pulmonary or cardiac issues. The integration of innovative technologies, such as artificial intelligence and telemedicine, is also influencing the market positively by enhancing patient monitoring and support capabilities.

Opportunities to be explored within the US market include the expansion of [ECMO](../../../reports/extracorporeal-membrane-oxygenation-machine-market-8119) training programs for healthcare providers, which can improve the usage and management of these machines in emergency situations. Additionally, partnerships between manufacturers and hospitals can enhance access to ECMO technologies, leading to better patient outcomes. With the increasing focus on personalized medicine, there is a chance for the development of specialized ECMO devices tailored to individual patient needs, thereby creating new avenues for growth.

Recent trends indicate a shift towards more portable ECMO systems, allowing for greater mobility and flexibility in patient care, particularly in transport medicine. The COVID-19 pandemic has accelerated the adoption of ECMO as a life-saving intervention for severe cases, prompting research and development efforts aimed at improving device efficiency and safety. Furthermore, collaboration between government agencies and medical institutions to establish guidelines and protocols for ECMO usage in the US continues to shape the landscape of this market, ensuring that advancements align with patient safety and treatment efficacy.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Extracorporeal Membrane Oxygenation Machine Market Drivers**

### **Rising Incidence of Respiratory Diseases**

The increase in the incidence of respiratory diseases in the United States is a significant driver for the US Extracorporeal Membrane Oxygenation Machine Market Industry. The Centers for Disease Control and Prevention (CDC) reported that chronic lower respiratory diseases caused more than 150,000 deaths in the US in 2021 alone, highlighting a concerning trend. As respiratory illnesses surge, the need for advanced treatments like Extracorporeal Membrane Oxygenation (ECMO) has become critical.

Hospitals are expanding their ECMO capacities, leading to greater demand for ECMO machines. With increased recognition of ECMO's role in effectively managing severe respiratory distress, the market's growth trajectory is robustly supported by these statistics. Moreover, the American Thoracic Society is actively educating healthcare providers regarding ECMO's benefits, fostering wider adoption in critical care settings. This indicates not only an increase in machines necessary for treatment but also a shift towards more sophisticated respiratory disease management in hospitals.

### **Technological Advancements in ECMO Devices**

Ongoing advancements in technology have greatly enhanced the functionality and efficiency of Extracorporeal Membrane Oxygenation machines in the United States. Research and Development (R&D) efforts by companies like Medtronic and Abbott in the ECMO sector have led to the introduction of devices that are smaller, more portable, and easier to use. This effectively broadens the range of healthcare settings where ECMO can be employed, including smaller hospitals and emergency response units.

Furthermore, improvements in biocompatible materials and user interfaces promote patient safety and outcomes, making ECMO a more attractive option for both hospitals and patients. Enhanced ECMO systems have shown a potential to decrease the duration of hospital stays for critical patients, as evidenced by studies published in journals such as The Journal of Thoracic Disease. This technological prowess will significantly stimulate market growth in the US ECMO market.

### **Increasing Investments in Healthcare Infrastructure**

Significant investments in healthcare infrastructure are driving the US Extracorporeal Membrane Oxygenation Machine Market Industry. According to the American Hospital Association, total hospital spending in the United States reached approximately $1 trillion in 2022, with a considerable portion dedicated to upgrading critical care equipment. As hospitals strive to provide advanced care capabilities, procurement of ECMO machines is becoming a priority, as these systems offer essential life support during critical health emergencies.

With the ongoing evolution of healthcare policies supporting the acquisition of high-cost medical devices, hospitals are more willing to allocate budgets toward ECMO technology. This trend is further supported by grants and funding initiatives from government programs such as the Health Resources and Services Administration that aim to bolster critical care capacities, particularly in response to the increasing demand for advanced therapeutic interventions in the wake of the COVID-19 pandemic.

### **Increasing Awareness of ECMO Benefits**

The growing awareness regarding the efficacy and benefits of Extracorporeal Membrane Oxygenation is propelling the US ECMO market. Educational campaigns led by organizations such as the Extracorporeal Life Support Organization (ELSO) are crucial in disseminating knowledge among healthcare professionals and the public. With numerous studies demonstrating ECMO's effectiveness in saving lives during severe cardiac and respiratory failures, an increased focus on best practices and patient outcomes has been established.

The ELSO guidelines, updated regularly to reflect new evidence, enhance clinician confidence in utilizing ECMO as a critical care intervention. As hospitals adopt these protocols, the integration of ECMO technology becomes more prevalent, further driving market growth. Enhanced training programs and seminars initiated by medical associations are continuously raising awareness, leading to higher demand for ECMO machines across the healthcare landscape.

## **US Extracorporeal Membrane Oxygenation Machine Market Segment Insights**

### **Extracorporeal Membrane Oxygenation Machine Market Application Insights**

The Application segment within the US Extracorporeal Membrane Oxygenation Machine Market plays a critical role in enhancing the overall clinical outcomes in patients requiring mechanical circulatory support. This segment encompasses three primary areas: Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass, each serving distinct yet interrelated functions.

Cardiac Support is particularly significant as it addresses severe heart failure, allowing patients to recover while maintaining vital organ perfusion. The increasing prevalence of heart diseases in the US has contributed to the demand for effective cardiac support solutions, highlighting its importance in critical care settings.

Respiratory Support focuses on patients suffering from acute respiratory failure or conditions such as ARDS. This area is gaining traction due to the growing incidence of respiratory illnesses and the need for advanced intervention methods, especially during respiratory pandemics. The Respiratory Support aspect is seen as a life-saving measure, allowing for lung rest while facilitating gas exchange.

The role of Cardiopulmonary Bypass during surgical procedures remains essential, particularly in cardiac surgeries. This function ensures a controlled environment for surgeons while seamlessly maintaining blood circulation and oxygenation, which is vital during intricate heart operations.

Overall, the segmentation of the US Extracorporeal Membrane Oxygenation Machine Market into these applications indicates a strategic approach to addressing various patient needs within the healthcare system. Advances in technology, along with ongoing Research and Development initiatives, are shaping the future of these applications, offering new hope for patients requiring advanced forms of life support. As healthcare providers increasingly adopt these solutions, the market continues to evolve, driven by the urgent demands of critical care environments across the United States.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Extracorporeal Membrane Oxygenation Machine Market End User Insights**

The US Extracorporeal Membrane Oxygenation Machine Market exhibits a diverse End User landscape that includes Hospitals, Ambulatory Surgical Centers, and Home Care Settings, each playing a pivotal role in the delivery of advanced respiratory care. Hospitals serve as the primary setting for the use of Extracorporeal Membrane Oxygenation machines due to their intensive care units equipped with specialized personnel and resources. This segment demonstrates a significant demand driven by the increasing prevalence of severe cardiac and respiratory illnesses.

Ambulatory Surgical Centers, while relatively smaller in number, contribute by providing efficient and timely access to Extracorporeal Membrane Oxygenation for patients requiring less complex procedures. Their ability to offer high-quality care at reduced costs positions them as an attractive option in the market.

Additionally, Home Care Settings are emerging as an important trend, reflecting a shift towards patient-centered care, allowing individuals to receive treatment in the comfort of their homes, thus enhancing quality of life. This growth is supported by advances in technology that allow for more portable and user-friendly devices. Overall, the segmentation within the US Extracorporeal Membrane Oxygenation Machine Market highlights the varied needs and preferences in health care delivery that drive the demand across different settings.

### **Extracorporeal Membrane Oxygenation Machine Market Product Type Insights**

The US Extracorporeal Membrane Oxygenation Machine Market is notably categorized into various product types, with each type serving distinct medical needs in critical care environments. Venoarterial ECMO is crucial for patients requiring cardiac support, as it provides both oxygenation and cardiac assistance, often used in cases of severe cardiac failure or during surgeries.

In contrast, Venovenous ECMO primarily focuses on patients with severe respiratory failure, offering robust pulmonary support without significantly affecting cardiac output; its use has risen due to an increase in respiratory conditions exacerbated by factors such as the COVID-19 pandemic.

Arteriovenous ECMO, while less common, plays a vital role in specific settings, particularly where both oxygenation and blood flow are required, often utilized in unique cases like severe burns or trauma. The innovation in ECMO technologies and enhancements in patient management protocols indicate a growing trend in their application, driven by the increasing incidences of respiratory ailments and cardiac complications in the US population. Overall, these product types are essential in providing advanced life support, significantly impacting patient survival rates and recovery in critical care scenarios.

### **Extracorporeal Membrane Oxygenation Machine Market Component Insights**

The Component segment of the US Extracorporeal Membrane Oxygenation Machine Market plays a crucial role in ensuring the efficiency and performance of ECMO systems. Major components such as Membrane Oxygenators, Blood Pumps, and Heat Exchangers are vital for the effective functioning of these life-saving machines.

Membrane Oxygenators are significant as they facilitate gas exchange, which is essential for patients with severe cardiac and respiratory failure. Blood Pumps are also dominant in this segment, as they ensure smooth and continuous blood flow, which is critical for the patient's stability during treatment.

Heat Exchangers maintain optimal body temperature, enhancing patient care during extracorporeal procedures. This segment is characterized by rapid technological advancements and increasing demand for improvements in ECMO devices, driven by rising incidence of cardiac diseases in the US. As healthcare facilities continue to adopt advanced ECMO technologies, the Component segment is expected to experience substantial growth. The growing awareness and education surrounding ECMO usage, combined with a well-established regulatory framework, provide significant opportunities for innovation within the components of ECMO machines, contributing to the overall market dynamics.

## **US Extracorporeal Membrane Oxygenation Machine Market Key Players and Competitive Insights**

The US Extracorporeal Membrane Oxygenation Machine Market exhibits a robust competitive landscape characterized by a range of key players that are continually innovating and expanding their portfolios to cater to the increasing demand for advanced cardiac and respiratory support systems. With a growing prevalence of conditions requiring life support interventions, particularly among critically ill patients, the market is witnessing significant investments in research and development from various companies.

These organizations are not only aiming to improve the efficacy and efficiency of their products but are also working on enhancing user experiences through better design and technology integration, resulting in an increasingly dynamic marketplace. Competitive strategies such as partnerships, mergers, and acquisitions also play a considerable role in shaping market dynamics, allowing for enhanced product offerings and improved market access.

Nipro has established a noteworthy presence in the US Extracorporeal Membrane Oxygenation Machine Market, driven primarily by its commitment to innovation and quality. The company's strengths lie in its comprehensive range of oxygenation machines designed to meet strict regulatory standards while also ensuring reliability and safety for patients requiring ECMO support. Nipro's manufacturing capabilities and distribution networks enable it to serve diverse healthcare facilities effectively, ensuring that hospitals have access to the necessary equipment when critically needed.

Their focus on user-friendly interfaces and integration of advanced technology into their devices has positioned them favorably among healthcare professionals, thereby enhancing their reputation in this specialized market segment. Nipro's strategic initiatives focused on enhancing product performance and reliability have played a pivotal role in maintaining competitive advantages in the US market.

LivaNova, on the other hand, is recognized for its advanced medical technology, particularly in the field of cardiac surgery and ECMO systems within the US market. The company's key products include a variety of extracorporeal membrane oxygenation machines specifically engineered for various clinical applications, showcasing LivaNova's commitment to meeting diverse patient needs. Their market presence is bolstered by a notable array of partnerships and alliances aimed at expanding their service capabilities and product offerings. LivaNova's strengths lie in its continuous focus on research and development, which allows for the introduction of cutting-edge technologies and innovations.

Furthermore, the company has engaged in strategic mergers and acquisitions, positioning itself effectively to broaden its market reach and enhance its product line within the US. By leveraging these advantages, LivaNova aspires to maintain its stronghold in the competitive landscape of the Extracorporeal Membrane Oxygenation Machine Market.

### **Key Companies in the US Extracorporeal Membrane Oxygenation Machine Market Include**

## **US Extracorporeal Membrane Oxygenation Machine Market Industry Developments**

Recent developments in the US Extracorporeal Membrane Oxygenation Machine Market have been marked by advancements and increasing demand driven by critical care needs. In September 2023, Nipro made strides in enhancing its product offerings while LivaNova announced innovative upgrades to its ECMO technology, aiming to improve patient outcomes. Additionally, Medtronic in August 2023 reported a substantial growth in market valuation due to its expanded service capabilities, positively impacting the overall market dynamics.

Mergers and acquisitions have also played a role; for instance, in July 2023, Getinge acquired a smaller biomedical firm to strengthen its position in critical care solutions. The growing prevalence of respiratory conditions and the need for advanced lung support systems have fueled market growth, with companies like Abbott Laboratories and Hamilton Medical actively investing in Research and Development.

The market's valuation has significantly increased over the past 2-3 years, reflecting rising healthcare expenses and technological innovations. Significant events during this period include the FDA's recent approvals for new ECMO devices in May 2022 and a notable partnership between Terumo and Xenios AG in November 2021 to enhance delivery systems for organ support therapies.

## **US Extracorporeal Membrane Oxygenation Machine Market Segmentation Insights**

### **Extracorporeal Membrane Oxygenation Machine Market Application Outlook**

### **Extracorporeal Membrane Oxygenation Machine Market End User Outlook**

### **Extracorporeal Membrane Oxygenation Machine Market Product Type Outlook**

- Venoarterial ECMO
- Venovenous ECMO
- Arteriovenous ECMO
- **Extracorporeal Membrane Oxygenation Machine Market Component Outlook**
- Membrane Oxygenator
- Blood Pumps
- Heat Exchangers

## Market Drivers

### Growing Awareness of ECMO Benefits

The rising awareness among healthcare professionals and patients regarding the benefits of ECMO is influencing the extracorporeal membrane-oxygenation-machine market. Educational initiatives and training programs are being implemented to inform medical staff about the advantages of ECMO in treating severe respiratory and cardiac conditions. As more clinicians recognize the efficacy of ECMO in saving lives, the demand for these machines is likely to increase. Furthermore, patient advocacy groups are also playing a role in promoting ECMO as a viable treatment option. This heightened awareness is expected to drive the extracorporeal membrane-oxygenation-machine market forward, as more healthcare facilities seek to incorporate ECMO into their treatment protocols.

### Rising Incidence of Respiratory Diseases

The increasing prevalence of respiratory diseases in the US is a notable driver for the extracorporeal membrane-oxygenation-machine market. Conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia are on the rise, necessitating advanced medical interventions. According to recent health statistics, respiratory diseases account for a significant portion of hospital admissions, leading to a heightened demand for ECMO machines. This trend is likely to continue, as the aging population is more susceptible to such ailments. Consequently, healthcare facilities are investing in extracorporeal membrane-oxygenation machines to enhance patient outcomes, thereby propelling market growth. The extracorporeal membrane-oxygenation-machine market is expected to see a surge in adoption rates as hospitals aim to improve their critical care capabilities.

### Technological Innovations in ECMO Systems

Technological advancements in ECMO systems are transforming the extracorporeal membrane-oxygenation-machine market. Innovations such as miniaturization, improved biocompatibility of materials, and enhanced monitoring systems are making ECMO machines more efficient and user-friendly. These advancements not only improve patient safety but also reduce the operational costs associated with ECMO procedures. For instance, the integration of artificial intelligence in monitoring systems allows for real-time data analysis, which can lead to better clinical decisions. As hospitals increasingly adopt these advanced systems, the extracorporeal membrane-oxygenation-machine market is likely to experience robust growth. The potential for improved patient outcomes through these innovations is a compelling factor driving market expansion.

### Increased Investment in Healthcare Infrastructure

The ongoing investment in healthcare infrastructure across the US is a significant driver for the extracorporeal membrane-oxygenation-machine market. With the expansion of hospitals and critical care units, there is a growing need for advanced medical equipment, including ECMO machines. Government initiatives aimed at enhancing healthcare facilities are likely to boost the procurement of these machines. Reports indicate that healthcare spending in the US is projected to grow at a rate of approximately 5.4% annually, which could lead to increased budgets for critical care technologies. This trend suggests that the extracorporeal membrane-oxygenation-machine market will benefit from heightened demand as healthcare providers seek to upgrade their capabilities.

### Regulatory Support for Advanced Medical Technologies

Regulatory support for advanced medical technologies is a crucial driver for the extracorporeal membrane-oxygenation-machine market. The US Food and Drug Administration (FDA) has been actively streamlining the approval processes for innovative medical devices, including ECMO machines. This regulatory environment encourages manufacturers to invest in research and development, leading to the introduction of more advanced and effective ECMO systems. As regulatory barriers decrease, the market is likely to see an influx of new products, enhancing competition and driving down costs. This trend indicates that the extracorporeal membrane-oxygenation-machine market will continue to evolve, providing healthcare providers with a wider array of options to improve patient care.

## Future Outlook

The [Extracorporeal Membrane Oxygenation Machine Market](https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119) is projected to grow at a 6.27% CAGR from 2025 to 2035, driven by technological advancements and increasing patient demand.

**New opportunities:**

- Development of portable ECMO systems for home care settings. Integration of AI for predictive analytics in patient management. Expansion of training programs for ECMO specialists in hospitals.

By 2035, the market is expected to achieve substantial growth, reflecting advancements and increased adoption.

## Segment Insights

### By Application: Cardiac Support (Largest) vs. Respiratory Support (Fastest-Growing)

The US extracorporeal membrane-oxygenation-machine market shows a significant distribution in application segments, with Cardiac Support leading the charge due to its essential role in critical care settings. This segment commands a majority share, driven by increased prevalence of cardiac conditions and the necessity for advanced support technologies. Respiratory Support, while smaller overall, is rapidly gaining traction, reflecting a growing awareness and need for enhanced respiratory therapies.

Growth trends indicate a robust expansion in both segments, propelled by advancements in technology and increasing investments in healthcare infrastructure. Cardiac Support benefits from its established presence and critical applications in surgeries, whereas Respiratory Support is emerging as a response to rising respiratory diseases and post-COVID recovery needs. The ongoing innovation in ECMO systems further fuels this growth, attracting more healthcare facilities to adopt these life-saving machines.

Cardiac Support (Dominant) vs. Respiratory Support (Emerging)

Cardiac Support is the dominant application within the US extracorporeal membrane-oxygenation-machine market, commonly utilized for patients undergoing serious cardiac events, particularly during surgeries. This segment is characterized by its reliance on sophisticated ECMO technology to provide comprehensive care. In contrast, Respiratory Support is recognized as an emerging segment, increasingly vital for managing respiratory failures and providing crucial therapy for conditions such as ARDS. The growing prevalence of respiratory ailments and a heightened focus on emergency preparedness have established Respiratory Support as a pivotal player, indicating a shift in market dynamics and an increasing demand for these specialized machines.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The US extracorporeal membrane-oxygenation-machine market is primarily dominated by hospitals, which hold the largest share due to their extensive patient base and the need for advanced respiratory care solutions. Ambulatory surgical centers are emerging as significant players, capturing a growing share of the market as they adopt more sophisticated medical technologies to enhance patient care and reduce costs.

Growth trends in this segment are driven by increasing patient demand for respiratory support and technological advancements in ECMO machines. Factors such as a rising prevalence of chronic respiratory diseases and increased awareness about ECMO's benefits are propelling the adoption in surgical centers, while hospitals continue to expand capabilities and improve infrastructure dedicated to high-acuity care.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals remain the dominant segment in the US extracorporeal membrane-oxygenation-machine market due to their comprehensive care capabilities and extensive resources. They are equipped with advanced ECMO technologies, a skilled workforce, and the infrastructure to manage complex cases. Conversely, ambulatory surgical centers are emerging with innovative ECMO applications that cater to outpatient needs, offering flexibility and cost-effective solutions for patients requiring respiratory support. These settings benefit from advancements in technology that allow them to conduct procedures with minimal inpatient stays, thereby enhancing patient throughput and satisfaction.

### By Product Type: Venoarterial ECMO (Largest) vs. Venovenous ECMO (Fastest-Growing)

In the US extracorporeal membrane-oxygenation-machine market, Venoarterial ECMO currently holds the largest share among the product types, demonstrating its crucial role in critical care settings. Venovenous ECMO, while smaller in share, is gaining traction due to its effectiveness in providing respiratory support in various patient demographics, which influences overall market dynamics and preferences.

The growth trends in this segment are primarily driven by advancements in technology and increasing awareness regarding the benefits of ECMO systems in life-threatening situations. As hospitals adopt more sophisticated technologies, the demand for both Venoarterial and Venovenous ECMO solutions is expected to rise, with Venovenous ECMO emerging as a preferred option for patients requiring extended treatment.

Venoarterial ECMO (Dominant) vs. Venovenous ECMO (Emerging)

Venoarterial ECMO serves as the dominant solution in the US extracorporeal membrane-oxygenation-machine market, primarily utilized for patients with severe cardiac failure, processing both respiratory and cardiac support needs. Its established presence is bolstered by extensive clinical use over the years, solidifying its market leadership position. Conversely, Venovenous ECMO is emerging rapidly, catering to patients with respiratory failure, and is increasingly favored in critical care due to its ability to manage cases requiring extended respiratory support. This growing preference reflects the shift in treatment protocols as medical professionals seek optimal outcomes for diverse patient scenarios.

### By Component: Membrane Oxygenator (Largest) vs. Blood Pumps (Fastest-Growing)

In the US extracorporeal membrane-oxygenation-machine market, the component segment exhibits a diverse share distribution among its values. The Membrane Oxygenator stands out as the largest segment, holding a significant portion of the market, followed by Blood Pumps and Heat Exchangers. Blood Pumps have been capturing increasing attention due to their critical role in enhancing circulation during ECMO procedures, while Heat Exchangers maintain a steady presence in the market due to their essential function in maintaining patient temperatures. 

The growth trends in this segment reflect advancements in technology and a rising demand for better medical devices. The Membrane Oxygenator is characterized by steady demand driven by its fundamental importance in ECMO setups. Conversely, Blood Pumps are experiencing rapid growth, propelled by innovations and an increase in ECMO procedures linked to respiratory failure and cardiac support, highlighting the urgency for efficient blood flow management.

Membrane Oxygenator (Dominant) vs. Heat Exchangers (Emerging)

The Membrane Oxygenator is a dominant force in the component segment, known for its pivotal role in gas exchange during extracorporeal life support. With its established technology and reliability, it accounts for a substantial part of the market's operational framework. On the other hand, Heat Exchangers are emerging with increasing relevance due to their capacity to manage patient temperatures during critical procedures. This technology is gaining traction as healthcare practices emphasize better patient outcomes. While Membrane Oxygenators have a proven history, Heat Exchangers are becoming indispensable, driven by their ability to adapt to new medical protocols and a growing emphasis on procedural efficiency.

## Competitive Benchmarking

The extracorporeal membrane-oxygenation-machine market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for advanced respiratory support systems. Key players such as Medtronic (US), Getinge (SE), and LivaNova (GB) are strategically positioned to leverage innovation and expand their market presence. Medtronic (US) focuses on enhancing its product portfolio through continuous innovation, while Getinge (SE) emphasizes partnerships and collaborations to strengthen its market position. LivaNova (GB) appears to be concentrating on regional expansion, particularly in North America, to capture a larger share of the growing market. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological differentiation and customer-centric solutions.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure is moderately fragmented, with several key players influencing the competitive dynamics. This fragmentation allows for a variety of strategies to coexist, fostering innovation and competition among the major companies.
In October Medtronic (US) announced the launch of a new generation of its extracorporeal membrane oxygenation systems, which incorporate advanced AI algorithms for real-time patient monitoring. This strategic move is likely to enhance patient outcomes and streamline clinical workflows, positioning Medtronic (US) as a leader in technological innovation within the market. The integration of AI into their systems may also provide a competitive edge by improving decision-making processes in critical care settings.
In September Getinge (SE) entered into a strategic partnership with a leading healthcare technology firm to develop next-generation ECMO solutions. This collaboration is expected to accelerate product development and enhance the company’s ability to respond to evolving market needs. By aligning with a technology partner, Getinge (SE) may strengthen its innovation capabilities and expand its product offerings, thereby enhancing its competitive positioning.
In August LivaNova (GB) expanded its manufacturing capabilities in the US by investing in a new facility dedicated to the production of ECMO devices. This investment reflects LivaNova's commitment to meeting the increasing demand for advanced respiratory support systems in the region. By localizing production, LivaNova (GB) could potentially reduce lead times and improve supply chain reliability, which are critical factors in the competitive landscape.
As of November current trends in the extracorporeal membrane-oxygenation-machine market include a strong emphasis on digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise for enhanced innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and innovative solutions that address the specific needs of healthcare providers and patients.

## Recent News & Developments

Recent developments in the US Extracorporeal Membrane Oxygenation Machine Market have been marked by advancements and increasing demand driven by critical care needs. In September 2023, Nipro made strides in enhancing its product offerings while LivaNova announced innovative upgrades to its ECMO technology, aiming to improve patient outcomes. Additionally, Medtronic in August 2023 reported a substantial growth in market valuation due to its expanded service capabilities, positively impacting the overall market dynamics.

Mergers and acquisitions have also played a role; for instance, in July 2023, Getinge acquired a smaller biomedical firm to strengthen its position in critical care solutions. The growing prevalence of respiratory conditions and the need for advanced lung support systems have fueled market growth, with companies like Abbott Laboratories and Hamilton Medical actively investing in Research and Development.

The market's valuation has significantly increased over the past 2-3 years, reflecting rising healthcare expenses and technological innovations. Significant events during this period include the FDA's recent approvals for new ECMO devices in May 2022 and a notable partnership between Terumo and Xenios AG in November 2021 to enhance delivery systems for organ support therapies.

## Report Scope

| MARKET SIZE 2024 | 456.6(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 485.23(USD Million) |
| MARKET SIZE 2035 | 891.2(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.27% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US) |
| Segments Covered | Application, End User, Product Type, Component |
| Key Market Opportunities | Advancements in technology and regulatory support enhance growth potential in the extracorporeal membrane-oxygenation-machine market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in the extracorporeal membrane-oxygenation-machine market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the projected market valuation for the US extracorporeal membrane-oxygenation-machine market by 2035?**
A: The projected market valuation for the US extracorporeal membrane-oxygenation-machine market by 2035 is $891.2 Million.

**Q: What was the overall market valuation in 2024?**
A: The overall market valuation in 2024 was $456.6 Million.

**Q: What is the expected CAGR for the US extracorporeal membrane-oxygenation-machine market during the forecast period 2025 - 2035?**
A: The expected CAGR for the US extracorporeal membrane-oxygenation-machine market during the forecast period 2025 - 2035 is 6.27%.

**Q: Which companies are considered key players in the US extracorporeal membrane-oxygenation-machine market?**
A: Key players in the market include Medtronic (US), Getinge (SE), LivaNova (GB), and Fresenius SE (DE), among others.

**Q: What are the main application segments of the US extracorporeal membrane-oxygenation-machine market?**
A: The main application segments include Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass.

**Q: What is the valuation range for the Cardiac Support application segment?**
A: The valuation range for the Cardiac Support application segment is $150.0 Million to $300.0 Million.

**Q: How do the end-user segments break down in terms of valuation?**
A: End-user segments include Hospitals with $300.0 Million to $600.0 Million, Ambulatory Surgical Centers with $100.0 Million to $200.0 Million, and Home Care Settings with $56.6 Million to $91.2 Million.

**Q: What are the product types available in the US extracorporeal membrane-oxygenation-machine market?**
A: Product types include Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO.

**Q: What is the valuation range for the Membrane Oxygenator component?**
A: The valuation range for the Membrane Oxygenator component is $200.0 Million to $400.0 Million.

**Q: What does the future hold for the US extracorporeal membrane-oxygenation-machine market?**
A: The future appears promising, with a projected growth leading to a market valuation of $891.2 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-extracorporeal-membrane-oxygenation-machine-market-14609*